Want to see SNDL full AI Analyst Report?
SNDL Stock Chart & Stats
$1.35
>-$0.01(-0.40%)
At close: 4:00 PM EDT
$1.35
>-$0.01(-0.40%)
Day’s Range― - ―
52-Week Range$1.17 - $2.89
Previous CloseN/A
Volume1.71M
Average Volume (3M)1.47M
Market Cap
$332.72M
Enterprise Value$320.28
Total Cash (Recent Filing)$186.57M
Total Debt (Recent Filing)$166.38M
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Nov 10, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding248,300,000
10 Day Avg. Volume1,176,354
30 Day Avg. Volume1,471,587
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)0.53
Price to Sales (P/S)0.62
P/FCF Ratio10.12
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$3.50Price Target Upside159.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.02
Revenue Forecast (FY)$921.96M
Bulls Say, Bears Say
Bulls Say
Balance Sheet FlexibilityA debt-free balance sheet backed by substantial unrestricted cash gives SNDL flexibility to fund operations, pursue strategic opportunities, and return capital without relying heavily on external financing. This financial capacity can help the company manage volatility while supporting longer-term growth initiatives.
International Medical Cannabis ReadinessCompleting the EU-GMP audit positions Atholville to supply regulated international medical cannabis markets, while its existing scale and expansion potential support operating leverage. This creates a structural avenue for geographic diversification and may strengthen SNDL’s competitive position in global medical cannabis.
U.S. Medical Cannabis ExpansionThe Parallel transaction gives SNDL indirect majority economic exposure to a sizable U.S. medical cannabis platform, expanding its retail and production footprint beyond Canada. Subject to approvals and direct control, the assets could materially broaden revenue scale and strategic reach over the coming periods.
Bears Say
Revenue And Profitability ContractionDeclining revenue alongside sharper gross-profit contraction and an operating loss indicates that recent margin improvements have not yet translated into durable earnings growth. Continued pressure across both core sectors could limit reinvestment capacity and make the path to consistent profitability more uncertain.
Cannabis Operations Margin CollapseThe collapse in cannabis-operations margin materially weakens the economics of SNDL’s production business, while management expects Jeeter-related inefficiencies to persist in coming months. Elevated production costs and the wider operating loss could delay dependable segment profitability even if sales stabilize.
Liquor Retail WeaknessLower same-store sales, revenue, and gross margin show that SNDL’s liquor retail segment is facing sustained volume and pricing pressure rather than simply a one-time earnings fluctuation. Increased promotional activity can protect demand but may continue to weigh on profitability and operating income.
SNDL News
SNDL FAQ
What was SNDL’s price range in the past 12 months?
SNDL lowest stock price was $1.17 and its highest was $2.89 in the past 12 months.
What is SNDL’s market cap?
SNDL’s market cap is $332.72M.
When is SNDL’s upcoming earnings report date?
SNDL’s upcoming earnings report date is Nov 10, 2026 which is in 56 days.
How were SNDL’s earnings last quarter?
SNDL released its earnings results on Jul 28, 2026. The company reported -$0.022 earnings per share for the quarter, missing the consensus estimate of -$0.004 by -$0.018.
Is SNDL overvalued?
According to Wall Street analysts SNDL’s price is currently Undervalued.
Does SNDL pay dividends?
SNDL does not currently pay dividends.
What is SNDL’s EPS estimate?
SNDL’s EPS estimate is -0.01.
How many shares outstanding does SNDL have?
SNDL has 248,300,000 shares outstanding.
What happened to SNDL’s price movement after its last earnings report?
SNDL reported an EPS of -$0.022 in its last earnings report, missing expectations of -$0.004. Following the earnings report the stock price went down -9.63%.
Which hedge fund is a major shareholder of SNDL?
Currently, no hedge funds are holding shares in SNDL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SNDL Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.50 (159.26% Upside)
$3.50 (159.26% Upside)
Blogger Sentiment
Bullish
SNDL Sentiment 75%
Sector Average 62%
Sector Average 62%
Hedge Fund Trend
Decreased
By 18.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $53.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 0.5%
Last 30 Days ▼ 1.3%
Last 30 Days ▼ 1.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.93%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-4.53%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
SNDL
SNDL Inc. is a Canadian firm engaged in the cultivation, distribution, and sale of cannabis products across the country. Its operations are organized into two distinct segments: Cannabis Operations and Retail Operations. Through its Cannabis Operations, the company manages the growing, supplying, and selling of cannabis specifically for the adult-use market. Meanwhile, its Retail Operations segment is responsible for the direct private sale of recreational cannabis via a network of both corporate-owned and franchised retail outlets. SNDL also produces and distributes a range of inhalable cannabis products, including dried flower, pre-rolled joints, and vape cartridges. These items are marketed under several key brands, such as Top Leaf, Sundial Cannabis, Palmetto, and Grasslands. The company, originally incorporated in 2006 as Sundial Growers Inc., officially adopted its current name, SNDL Inc., in July 2022. Its main corporate office is situated in Calgary, Canada.
SNDL Company Deck
SNDL Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The quarter presented a mixed picture: operational performance was challenged with declines in revenue, gross profit and segment-level profitability (notably in cannabis operations and liquor retail), driven by market softness and production ramp inefficiencies (Jeeter). Offsetting these headwinds, SNDL entered transformational capital and strategic positions — strong liquidity (CAD 183.2M), zero debt, accelerated share repurchases (~7% reduction in shares outstanding), deployment of profit enhancement initiatives (>CAD 20M expected), modest improvement in free cash flow, and the completion of a major parallel restructuring milestone that opens access to a sizeable U.S. medical cannabis platform with material upside. Given substantial near-term operational challenges balanced against meaningful balance sheet strength and strategic optionality, the call’s tone is cautiously constructive but mixed.View all SNDL earnings summariesSNDL Stock 12 Month Forecast
Average Price Target
$3.50
▲(159.26% Upside)
Technical Analysis
Ownership Overview
2.52% Insiders
0.22% Mutual Funds
5.13% Other Institutional Investors
88.87% Public Companies and
Individual Investors